RMTC reports on uniform drug rules
« Return to News
"Throughout 2014, the RMTC staff has traveled extensively and spent innumerable hours consulting with state regulators and others to assist in the full implementation of these new model rules that are so important to the safety and integrity of horse racing,” said Dr. Dionne Benson, executive director of the RMTC. "We thank all of those who have worked in good faith to accomplish an unprecedented level of uniformity in 2014, and look forward to continuing the effort in 2015 and beyond.”
By early 2015, racing states operating under the Controlled Therapeutic Medication Schedule are anticipated to increase from four to at least 16 – a 300% improvement since January 2014. The Schedule identifies medications that have been recognized as necessary for the routine treatment of illness or injury in the horse. Arkansas, California, Illinois, Indiana, Kentucky, Minnesota, New Jersey, New Mexico, New York, North Dakota, Oregon and West Virginia have or will soon join Delaware, Maryland, Massachusetts and Virginia in regulating therapeutic medications using the new Schedule.
By early 2015, the number of horse racing states utilizing RMTC-accredited labs and an external quality assurance program for their equine drug and medication testing services will increase from six to 23 – a 283% gain from just 12 months ago. The laboratory accreditation and quality assurance programs were built upon protocols established by the World Anti-Doping Agency, the gold standard in human competition. Arizona, Arkansas, Colorado, Delaware, Idaho, Indiana, Maryland, Massachusetts, Minnesota, Nebraska, New Jersey, North Dakota, Oklahoma, Oregon, Washington, West Virginia and Wyoming have or will soon join California, Kentucky, Maine, New Mexico, Ohio and Virginia as states using only RMTC-accredited lab testing services. Labs in New York and Pennsylvania are expected to be RMTC-accredited sometime in early 2015, and Texas has recently applied for RMTC accreditation.
States that have implemented the MMV penalty system will increase no less than 200%, from three in January 2014 to at least nine by early 2015. The MMV penalty system – designed to work in a manner similar to the way states track an individual's traffic violations – provides for enhanced penalties for individuals who accumulate multiple medication violations, regardless of the jurisdiction in which they occur. Arkansas, Colorado, Indiana, Maryland, New Jersey and North Dakota have or will soon join Delaware, Massachusetts and Virginia.
Those states requiring third-party administration of furosemide (commonly referred as Lasix) on race day are anticipated to rise from 13 in January 2014 to at least 16 by early 2015 – a 23% increase. Arkansas, California, Oregon and Pennsylvania will join Colorado, Delaware, Indiana, Kentucky, Maine, Maryland, Massachusetts Minnesota, New Jersey, North Dakota, Virginia and West Virginia in implementing this policy which restricts access to the horse on race day.
"We are very encouraged by the industry's willingness to embrace reform and urge all horse racing jurisdictions in the United States to adopt the reforms in their entirely without further delay,” said Alex Waldrop, chairman of the RMTC and president and CEO of the NTRA.
The RMTC consists of 23 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred, American Quarter Horse and Arabian racing. The organization works to develop and promote uniform rules, policies and testing standards at the national level; coordinate research and educational programs that seek to ensure the integrity of racing and the health and welfare of racehorses and participants; and protect the interests of the racing public.
For additional information, visit the RMTC website at rmtcnet.com or contact Hallie Lewis, RMTC director of communications, at (859) 224-2848.(RMTC)